<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Heart JournalScan</title>
	<atom:link href="http://blogs.bmj.com/heart-journalscan/feed/" rel="self" type="application/rss+xml" />
	<link>http://blogs.bmj.com/heart-journalscan</link>
	<description>Highlighted articles from non-cardiological journals relevant to cardiology</description>
	<lastBuildDate>Fri, 14 Jun 2013 19:47:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Escitalopram for the treatment of mental-stress induced myocardial ischaemia (MSIMI)</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/06/12/escitalopram-for-the-treatment-of-mental-stress-induced-myocardial-ischaemia-msimi/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/06/12/escitalopram-for-the-treatment-of-mental-stress-induced-myocardial-ischaemia-msimi/#comments</comments>
		<pubDate>Wed, 12 Jun 2013 21:18:41 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[General cardiology]]></category>
		<category><![CDATA[escitalopram]]></category>
		<category><![CDATA[ischaemia]]></category>
		<category><![CDATA[ischemia]]></category>
		<category><![CDATA[MSIMI]]></category>
		<category><![CDATA[stress]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1446</guid>
		<description><![CDATA[Over the last three decades a large body of research has investigated the link between emotional distress and myocardial ischaemia; mental stress-induced myocardial ischaemia (MSIMI) is associated with an increased risk of cardiovascular events and death. Recent studies on selective serotonin reuptake inhibitors (SSRIs) has show that they may reduce the mental stress-induced haemodynamic response, [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/06/12/escitalopram-for-the-treatment-of-mental-stress-induced-myocardial-ischaemia-msimi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fish oils for the primary prevention of cardiovascular disease?</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/06/12/fish-oils-for-the-primary-prevention-of-cardiovasular-disease/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/06/12/fish-oils-for-the-primary-prevention-of-cardiovasular-disease/#comments</comments>
		<pubDate>Wed, 12 Jun 2013 20:59:45 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[General cardiology]]></category>
		<category><![CDATA[fish oils]]></category>
		<category><![CDATA[n-3 fatty acids]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1443</guid>
		<description><![CDATA[Polyunsaturated fatty acids derived from fish oils have been shown to confer benefit following myocardial infarction, and in patients with heart failure. They are thought to be pleiotropic, effecting atherosclerosis, inflammation, thrombosis and arrythmogenesis with a minimal side effect profile. However, the role of these potentially attractive drugs in primary prevention remains unknown. In this [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/06/12/fish-oils-for-the-primary-prevention-of-cardiovasular-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does warfarin need to be stopped for device insertion?</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/06/12/does-warfarin-need-to-be-stopped-for-device-insertion/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/06/12/does-warfarin-need-to-be-stopped-for-device-insertion/#comments</comments>
		<pubDate>Wed, 12 Jun 2013 20:52:17 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[Electrophysiology]]></category>
		<category><![CDATA[General cardiology]]></category>
		<category><![CDATA[devices]]></category>
		<category><![CDATA[heparin]]></category>
		<category><![CDATA[pacemaker]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1440</guid>
		<description><![CDATA[Over 1.6 million pacing or cardioverter defibrillator (ICD) devices are implanted worldwide annually and up to 1/3 of this cohort have an indication for long-term anticoagulation therapy. Current guidelines suggest discontinuing the oral anticoagulant and initiating bridging therapy with heparin but this strategy is associated with increased costs, a short but high risk period of [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/06/12/does-warfarin-need-to-be-stopped-for-device-insertion/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beta-blockers lower mortality after non-cardiac surgery</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/05/22/beta-blockers-lower-mortality-after-noncardiac-surgery/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/05/22/beta-blockers-lower-mortality-after-noncardiac-surgery/#comments</comments>
		<pubDate>Wed, 22 May 2013 09:41:44 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[General cardiology]]></category>
		<category><![CDATA[beta-blockers]]></category>
		<category><![CDATA[surgery]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1428</guid>
		<description><![CDATA[The use of preoperative beta-blockade to minimise the cardiovascular risks of noncardiac surgery has remained controversial for some time, and recent studies have suggested that preoperative beta-blockade may be now decreasing as a result. The purpose of this study was to determine whether early preoperative exposure to beta-blockers could influence 30-day postoperative outcomes in patients [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/05/22/beta-blockers-lower-mortality-after-noncardiac-surgery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Familial hypercholesterolaemia: new genes found</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/05/22/familial-hypercholesterolaemia-new-genes-found/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/05/22/familial-hypercholesterolaemia-new-genes-found/#comments</comments>
		<pubDate>Wed, 22 May 2013 09:38:36 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[General cardiology]]></category>
		<category><![CDATA[Molecular Cardiology]]></category>
		<category><![CDATA[familial hypercholesterolaemia]]></category>
		<category><![CDATA[FH]]></category>
		<category><![CDATA[LDL]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1425</guid>
		<description><![CDATA[Familial hypercholesterolaemia is characterised by substantially raised plasma concentrations of low-density lipoprotein cholesterol (LDL-C) and is associated with a risk of coronary heart disease that is five to eight times higher than average. One charity has estimated a saving of £378.7 million from cardiovascular events avoided if all relatives of index cases were identified and [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/05/22/familial-hypercholesterolaemia-new-genes-found/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Triple therapy post-PCI? WOEST clarifies</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/05/22/triple-therapy-post-pci-woest-clarifies/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/05/22/triple-therapy-post-pci-woest-clarifies/#comments</comments>
		<pubDate>Wed, 22 May 2013 09:35:15 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[General cardiology]]></category>
		<category><![CDATA[Interventional cardiology]]></category>
		<category><![CDATA[clopidogrel]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1430</guid>
		<description><![CDATA[20-30% of patients taking oral anticoagulants also have ischaemic heart disease that requires treatment by percutaneous coronary intervention (PCI), thereby necessitating dual anti-platelet therapy to prevent stent thrombosis. However, the combination of dual anti-platelet therapy (DAP) and anti-coagulants is associated with a high annual risk of fatal and non-fatal bleeding episodes. This study hypothesised that [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/05/22/triple-therapy-post-pci-woest-clarifies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ICD detection intervals: long or short?</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/05/16/icd-detection-intervals-long-or-short/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/05/16/icd-detection-intervals-long-or-short/#comments</comments>
		<pubDate>Thu, 16 May 2013 06:56:56 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[Electrophysiology]]></category>
		<category><![CDATA[ATP]]></category>
		<category><![CDATA[ICD]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1422</guid>
		<description><![CDATA[Implantable cardioverter-defibrillators (ICDs) are now the standard of care in primary and secondary prevention of malignant arrhythmias, however with their increasing use it has been noted that ICD therapies &#8211; both appropriate and inappropriate &#8211; are associated with an increased risk of death and worsening of heart failure. The recent Multicenter Automatic Defibrillator Implantation Trial [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/05/16/icd-detection-intervals-long-or-short/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Long QT syndrome mutations and intrauterine fetal death</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/04/21/long-qt-syndrome-mutations-and-intrauterine-fetal-death/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/04/21/long-qt-syndrome-mutations-and-intrauterine-fetal-death/#comments</comments>
		<pubDate>Sun, 21 Apr 2013 10:42:09 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[Electrophysiology]]></category>
		<category><![CDATA[Molecular Cardiology]]></category>
		<category><![CDATA[intrauterine death]]></category>
		<category><![CDATA[LQTS]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1383</guid>
		<description><![CDATA[Intrauterine fetal death occurs in approximately 1 in every 160 pregnancies; postmortem evaluation often fails to find an underlying cause.  The objective of this paper was to determine the spectrum and prevalence of mutations in the three most common Long QT syndrome (LQTS) susceptible genes in a cohort of cases of unexplained intrauterine death. Retrospective [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/04/21/long-qt-syndrome-mutations-and-intrauterine-fetal-death/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Atherosclerosis: not just a disease of the modern age?</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/04/21/atherosclerosis-not-just-a-disease-of-the-modern-age/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/04/21/atherosclerosis-not-just-a-disease-of-the-modern-age/#comments</comments>
		<pubDate>Sun, 21 Apr 2013 10:34:45 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[Cardiovascular imaging]]></category>
		<category><![CDATA[General cardiology]]></category>
		<category><![CDATA[atherosclerosis]]></category>
		<category><![CDATA[CT]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1388</guid>
		<description><![CDATA[As life expectancy doubled between 1800 and 2000, atherosclerosis replaced infectious diseases as the main cause of death in the developed world. But is atherosclerosis a purely modern phenomenon, precipitated by lifestyle changes and an ageing population, or was it common in ancient societies too? Thompson et al. performed whole-body CT scans on 137 mummies [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/04/21/atherosclerosis-not-just-a-disease-of-the-modern-age/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CELLWAVE: bone marrow cells improve ventricular function</title>
		<link>http://blogs.bmj.com/heart-journalscan/2013/04/21/cellwave-bone-marrow-cells-improve-ventricular-function/</link>
		<comments>http://blogs.bmj.com/heart-journalscan/2013/04/21/cellwave-bone-marrow-cells-improve-ventricular-function/#comments</comments>
		<pubDate>Sun, 21 Apr 2013 10:26:29 +0000</pubDate>
		<dc:creator>Alistair Lindsay</dc:creator>
				<category><![CDATA[Heart Failure]]></category>
		<category><![CDATA[stem cells]]></category>

		<guid isPermaLink="false">http://blogs.bmj.com/heart-journalscan/?p=1389</guid>
		<description><![CDATA[In patients with chronic postinfarction heart failure, bone marrow-derived mononuclear cell (BMC) therapy has demonstrated mixed results to date.  One possible reason for this is that cell retention by the heart is more difficult in the stable setting in comparison to therapies given following acute myocardial infarction, however a recent discovery found that extracorporeal application [...]]]></description>
		<wfw:commentRss>http://blogs.bmj.com/heart-journalscan/2013/04/21/cellwave-bone-marrow-cells-improve-ventricular-function/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
